CIAM
ORIC icon

Caitong International Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Caitong International Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
1,252
+1,175
+1,526% +$10.7K ﹤0.01% 1082
2026
Q1 		$976 Sell
77
-7
-8% -$79 ﹤0.01% 1441
2025
Q4 		$687 Sell
84
-1,508
-95% -$17.4K ﹤0.01% 1423
2025
Q3 		$19.1K Buy
1,592
+325
+26% +$3.42K 0.01% 728
2025
Q2 		$12.9K Buy
1,267
+917
+262% +$6.16K 0.01% 640
2025
Q1 		$1.95K Buy
+350
New +$3.06K ﹤0.01% 1358

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caitong International Asset Management's ORIC Position: Q2 2026 in Review

Caitong International Asset Management increased its Oric Pharmaceuticals (ORIC) stake by 1,526% in Q2 2026, buying an estimated $10.7K and bringing the position to 1,252 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1082.

Caitong International Asset Management first reported a position in ORIC in Q1 2025 and has held it in 6 quarters since. The position peaked at $19.1K in Q3 2025. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Caitong International Asset Management held 1,252 shares of Oric Pharmaceuticals worth $13.6K as of Q2 2026.
  • Caitong International Asset Management bought 1,175 Oric Pharmaceuticals shares in Q2 2026, an estimated $10.7K.
  • Oric Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1082 holding.
  • Caitong International Asset Management first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Oric Pharmaceuticals position peaked at $19.1K in Q3 2025.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.